Related articles:

Spark Therapeutics Inc.: Spark Therapeutics Reports 2016 Financial Results and Business Highlights
February 22, 2017
February 22, 2017

Spark Therapeutics Inc.: Spark Therapeutics to Host Conference Call on Wednesday, Feb. 22 at 8:30 a.m. to Discuss 2016 Results
February 15, 2017
February 15, 2017

Spark Therapeutics Inc.: Spark Therapeutics Reports Second Quarter 2016 Financial Results and Recent Business Highlights
August 10, 2016
August 10, 2016

Spark Therapeutics Inc.: Spark Therapeutics, Inc. to Host Conference Call on August 10th at 8:30a.m. to Discuss Second Quarter 2016 Results
August 02, 2016
August 2, 2016

Spark Therapeutics Inc.: Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity
June 13, 2016
June 13, 2016

Spark Therapeutics Inc.: Spark Therapeutics, Inc. to Host Conference Call on Monday June 13th at 8:30 a.m. to Discuss SPK-9001 Phase 1/2 Data for the Treatment of Hemophilia B Presented at EHA
June 09, 2016
June 9, 2016

Spark Therapeutics Inc.: Spark Therapeutics, Inc. to Host Conference Call on May 4th at 8:30a.m. to Discuss First Quarter 2016 Results
April 27, 2016
April 27, 2016

Spark Therapeutics Inc.: Spark Therapeutics Reports 2015 Financial Results and Business Highlights
March 09, 2016
March 9, 2016

Spark Therapeutics Inc.: Spark Therapeutics, Inc. to Host Conference Call on March 9th at 8:30 a.m. to Discuss 2015 Results
March 02, 2016
March 2, 2016

Spark Therapeutics Inc.: Spark Therapeutics Announces Addition to NASDAQ Biotechnology Index
December 14, 2015
December 14, 2015

Spark Therapeutics Inc.: Spark Therapeutics Reports Second Quarter 2015 Results
August 05, 2015
August 5, 2015

Spark Therapeutics Inc.: Spark Therapeutics, Inc. to Host Conference Call on August 5th at 8:30a.m. to Discuss Second Quarter 2015 Results
July 29, 2015
July 29, 2015

Pin It on Pinterest

Share This